Inhibition of choriodecidual cytokine production and inflammatory gene expression by selective I-B kinase (IKK) inhibitors

British Journal of Pharmacology

Volumn 160, Issue 7, 2010, Pages 1808-1822

  De Silva, D ^a   Mitchell, M D ^a,b   Keelan, J A ^a,c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

choriodecidua; gene expression; I B kinase; inflammation; lipopolysaccharide; NF B; preterm labour

Indexed keywords

[5 (4 FLUOROPHENYL) 2 UREIDO]THIOPHENE 3 CARBOXAMIDE; ANTIINFLAMMATORY AGENT; CYTOKINE; I KAPPA B; LIPOPOLYSACCHARIDE; OLIGONUCLEOTIDE; PARTHENOLIDE; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL VIABILITY; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; NUCLEOTIDE SEQUENCE; PREMATURITY; PRIORITY JOURNAL; PROPHYLAXIS;

CELL NUCLEUS; CELL SURVIVAL; CELLS, CULTURED; CHORIONIC VILLI; CYTOKINES; CYTOPLASM; DECIDUA; ENZYME INHIBITORS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HUMANS; I-KAPPA B KINASE; IMMUNOBLOTTING; LIPOPOLYSACCHARIDES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77954328812     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00839.x     Document Type: Article

References (58)

1. Adams Waldorf KM, Persing D, Novy MJ, Sadowsky DW, Gravett MG (2008). Pretreatment with toll-like receptor 4 antagonist inhibits lipopolysaccharide- induced preterm uterine contractility, cytokines, and prostaglandins in rhesus monkeys. Reprod Sci 15:121 127.
2. Beloosesky R, Gayle DA, Amidi F, Nunez SE, Babu J, Desai M et al. (2006). N-acetyl-cysteine suppresses amniotic fluid and placenta inflammatory cytokine responses to lipopolysaccharide in rats. Am J Obstet Gynecol 194:268 273.
3. Birrell MA, Hardaker E, Wong S, McCluskie K, Catley M, De Alba J et al. (2005). Ikappa-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma. Am J Respir Crit Care Med 172:962 971.
4. Brar H, Einarson A (2008). Effects and treatment of inflammatory bowel disease during pregnancy. Can Fam Physician 54:981 983.
5. Buhimschi IA, Buhimschi CS, Weiner CP (2003). Protective effect of N-acetylcysteine against fetal death and preterm labor induced by maternal inflammation. Am J Obstet Gynecol 188:203 208.
6. Burke JR, Pattoli MA, Gregor KR, Brassil PJ, MacMaster JF, McIntyre KW et al. (2003). BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. J Biol Chem 278:1450 1456.
7. Calzado MA, Bacher S, Schmitz ML (2007). NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer. Curr Med Chem 14:367 376.
8. Chariot A (2009). The NF-kappaB-independent functions of IKK subunits in immunity and cancer. Trends Cell Biol 19:404 413.
9. Denizot F, Lang R (1986). Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89:271 277.
10. Descargues P, Sil AK, Sano Y, Korchynskyi O, Han G, Owens P et al. (2008). IKKalpha is a critical coregulator of a Smad4-independent TGFbeta-Smad2/3 signaling pathway that controls keratinocyte differentiation. Proc Natl Acad Sci U S A 105:2487 2492.
11. DiGiulio DB, Romero R, Amogan HP, Kusanovic JP, Bik EM, Gotsch F et al. (2008). Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS ONE 3:e3056.
12. Elovitz MA (2006). Anti-inflammatory interventions in pregnancy: now and the future. Semin Fetal Neonatal Med 11:327 332.
13. Gotsch F, Romero R, Kusanovic JP, Mazaki-Tovi S, Pineles BL, Erez O et al. (2007). The fetal inflammatory response syndrome. Clin Obstet Gynecol 50:652 683.
14. Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, Miething C et al. (2007). NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 130:918 931.
15. Hehner SP, Hofmann TG, Droge W, Schmitz ML (1999). The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex. J Immunol 163:5617 5623.
16. Holmgren C, Esplin MS, Hamblin S, Molenda M, Simonsen S, Silver R (2008). Evaluation of the use of anti-TNF-alpha in an LPS-induced murine model. J Reprod Immunol 78:134 139.
17. Hou Y, Li F, Karin M, Ostrowski MC (2008). Analysis of the IKKbeta/NF-kappaB signaling pathway during embryonic angiogenesis. Dev Dyn 237:2926 2935.
18. Hwang D, Fischer NH, Jang BC, Tak H, Kim JK, Lee W (1996). Inhibition of the expression of inducible cyclooxygenase and proinflammatory cytokines by sesquiterpene lactones in macrophages correlates with the inhibition of MAP kinases. Biochem Biophys Res Commun 226:810 818.
19. Karin M (2008). The IkappaB kinase - a bridge between inflammation and cancer. Cell Res 18:334 342.
20. Kawai T, Akira S (2007). Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 13:460 469.
21. Keelan JA, Mitchell MD (1998). The effects of a ceramide analogue, N-acetylsphingosine, on basal and tumor necrosis factor-alpha-stimulated production of prostaglandins and cytokines in gestational tissues. Prostaglandins Other Lipid Mediat 55:141 158.
22. Keelan JA, Blumenstein M, Helliwell RJ, Sato TA, Marvin KW, Mitchell MD (2003). Cytokines, prostaglandins and parturition - a review. Placenta 24 (Suppl. A S33 S46.
23. Keelan JA, Khan S, Yosaatmadja F, Mitchell MD (2009). Prevention of inflammatory activation of human gestational membranes in an ex-vivo model using a pharmacological NF-kappaB inhibitor. J Immunology 183:5270 5278.
24. Kishore N, Sommers C, Mathialagan S, Guzova J, Yao M, Hauser S et al. (2003). A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts. J Biol Chem 278:32861 32871.
25. Kobori M, Yang Z, Gong D, Heissmeyer V, Zhu H, Jung YK et al. (2004). Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex. Cell Death Differ 11:123 130.
26. Kondo Y, Fukuda K, Adachi T, Nishida T (2008). Inhibition by a selective IkappaB kinase-2 inhibitor of interleukin-1-induced collagen degradation by corneal fibroblasts in three-dimensional culture. Invest Ophthalmol Vis Sci 49:4850 4857.
27. Lappas M, Permezel M, Georgiou HM, Rice GE (2002). Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol Reprod 67:668 673.
28. Lappas M, Permezel M, Rice GE (2003). N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-kappaB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab 88:1723 1729.
29. Lappas M, Permezel M, Ho PW, Moseley JM, Wlodek ME, Rice GE (2004). Effect of nuclear factor-kappa B inhibitors and peroxisome proliferator- activated receptor-gamma ligands on PTHrP release from human fetal membranes. Placenta 25:699 704.
30. Lappas M, Yee K, Permezel M, Rice GE (2005). Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-kappa B and I kappa B kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro. Endocrinology 146:1491 1497.
31. Lee SE, Romero R, Park CW, Jun JK, Yoon BH (2008). The frequency and significance of intraamniotic inflammation in patients with cervical insufficiency. Am J Obstet Gynecol 198:633.e1 633.e8.
32. Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M et al. (1999). The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med 189:1839 1845.
33. Lin YZ, Yao SY, Veach RA, Torgerson TR, Hawiger J (1995). Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 270:14255 14258.
34. Lu YC, Yeh WC, Ohashi PS (2008). LPS/TLR4 signal transduction pathway. Cytokine 42:145 151.
35. Luppi P (2003). How immune mechanisms are affected by pregnancy. Vaccine 21:3352 3357.
36. Moutsopoulos NM, Madianos PN (2006). Low-grade inflammation in chronic infectious diseases: paradigm of periodontal infections. Ann N Y Acad Sci 1088:251 264.
37. Murthy V, Kennea NL (2007). Antenatal infection/inflammation and fetal tissue injury. Best Pract Res Clin Obstet Gynaecol 21:479 489.
38. Norgard B, Pedersen L, Christensen LA, Sorensen HT (2007). Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol 102:1406 1413. (Pubitemid 46976292)
39. Paintlia MK, Paintlia AS, Singh AK, Singh I (2008). Attenuation of lipopolysaccharide induced inflammatory response and phospholipids metabolism at the feto-maternal interface by N-Acetyl-cysteine. Pediatr Res 164:334 339.
40. Pande V, Ramos MJ (2005). NF-kappaB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors. Curr Med Chem 12:357 374.
41. Pandey MK, Sandur SK, Sung B, Sethi G, Kunnumakkara AB, Aggarwal BB (2007). Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-kappaB and NF-kappaB-regulated gene expression through direct inhibition of IkappaBalpha kinase beta on cysteine 179 residue. J Biol Chem 282:17340 17350.
42. Rahimi R, Nikfar S, Rezaie A, Abdollahi M (2008). Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis. Reprod Toxicol 25:271 275.
43. Redinbaugh MG, Turley RB (1986). Adaption of the bicinchoninic acid protein assay for use with microtiter plates and sucrose gradient fractions. Anal Biochem 153:267 261.
44. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel LA, Nien JK (2006). Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med 11:317 326.
45. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel L, Hassan S (2007a). The role of inflammation and infection in preterm birth. Semin Reprod Med 25:21 39.
46. Romero R, Gotsch F, Pineles B, Kusanovic JP (2007b). Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev 65:S194 S202.
47. Sadowsky DW, Adams KM, Gravett MG, Witkin SS, Novy MJ (2006). Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am J Obstet Gynecol 195:1578 1589.
48. Sato TA, Keelan JA, Mitchell MD (2003). Critical paracrine interactions between TNF-alpha and IL-10 regulate lipopolysaccharide-stimulated human choriodecidual cytokine and prostaglandin E2 production. J Immunol 170:158 166.
49. Schmid JA, Birbach A (2008). IkappaB kinase beta (IKKbeta/IKK2/IKBKB) - a key molecule in signaling to the transcription factor NF-kappaB. Cytokine Growth Factor Rev 19:157 165.
50. Shahin AY, Hassanin IM, Ismail AM, Kruessel JS, Hirchenhain J (2009). Effect of oral N-acetyl cysteine on recurrent preterm labor following treatment for bacterial vaginosis. Int J Gynaecol Obstet 104:44 48.
51. Smolinski AT, Pestka JJ (2003). Modulation of lipopolysaccharide-induced proinflammatory cytokine production in vitro and in vivo by the herbal constituents apigenin (chamomile), ginsenoside Rb(1) (ginseng) and parthenolide (feverfew). Food Chem Toxicol 41:1381 1390.
52. Smolinski AT, Pestka JJ (2005). Comparative effects of the herbal constituent parthenolide (Feverfew) on lipopolysaccharide-induced inflammatory gene expression in murine spleen and liver. J Inflamm 2:6.
53. Strnad J, Burke JR (2007). IkappaB kinase inhibitors for treating autoimmune and inflammatory disorders: potential and challenges. Trends Pharmacol Sci 28:142 148.
54. Sun SC, Ley SC (2008). New insights into NF-kappaB regulation and function. Trends Immunol 29:469 478.
55. Takada Y, Kobayashi Y, Aggarwal BB (2005). Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion. J Biol Chem 280:17203 17212.
56. Verstrepen L, Bekaert T, Chau TL, Tavernier J, Chariot A, Beyaert R (2008). TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. Cell Mol Life Sci 65:2964 2978.
57. Xu DX, Chen YH, Wang H, Zhao L, Wang JP, Wei W (2005). Effect of N-acetylcysteine on lipopolysaccharide-induced intra-uterine fetal death and intra-uterine growth retardation in mice. Toxicol Sci 88:525 533.
58. Yamamoto Y, Gaynor RB (2001). Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 107:135 142.